Can These 2 Biotechs Beat Eli Lilly and Novo Nordisk in Weight-Loss Drugs? - The Motley Fool
Altimmune, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $3.01
+11% in 7d after detection
Post-detection moves
1h
—
1d
+2.9%
3d
+5.8%
7d
+11%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS